While LILRB1-KD inhibited MM cell progression in vivo, LDL treatment significantly promoted MM progression in both LILRB1-KD and CTR-KD MM-bearing mice (Supplementary Fig. 5m–o), which aligns well with our in vitro data. The gene discussed is LILRB1; the disease is Miyoshi myopathy.